NASDAQ
Atossa Therapeutics, Inc. (ATOS) has a current ratio of 5.53x as of Monday, May 25, 2026. This represents a 77.68% decrease compared to its 12-month average of 24.75x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.